Association between Pyridoxal-5'-Phosphate Levels, Liver Homogenates and Serum Activities of Aminotransferases and De Ritis Ratio amongst Alcoholic Hepatitis Patients

Main Article Content

Forwah Jacques Ndeh
Ebot Walter Ojong
Uwem Okon Akpan
Immaculate Ihuoma Ekeagba
Mohmbashagle Ngangnchi Smella

Abstract

Aim: The current study assessed the association between Pyridoxal-5'-phosphate (PLP) levels, liver and serum activities of aminotransferases (ALT and AST) and De Ritis ratio (DRR) in ten subjects with alcoholic hepatitis (test group -TG) and 10 healthy subjects without alcoholic hepatitis (control group-CG) with mean age of 41 years of both genders who were attending the University of Calabar Teaching Hospital, Calabar, Nigeria.

Study Design: The current study was a randomized experimental designed work.

Place and Duration of Study: The study carried out in Chemical Pathology Unit, Department of Medical Lab Sciences, University of Calabar, Nigeria between December 2014 and December 2016.

Methodology: Appropriate samples were collected from both TG and CG after 8-10 hours fasting and treated using standard procedures. PLP was determined by techniques of Lumeng and co-workers, 1981 (reagents from New England Nuclear, Massachusetts, USA). Hepatic protein levels and aminotransferase activities were determined by spectrophotometric methods, (reagents from Sigma- Aldrich Company, USA). Liver biopsy specimens were obtained with a Klatskin needle for histology.

Results: Before PLP supplementation of liver homogenates a significant decreased in PLP levels, increased liver ALT and decreased AST activities were observed in test group. After one month of pyridoxine supplementation, there was a significant increase (p<0.02) in plasma PLP level in all groups with decreased serum AST and increased serum ALT activities ,while liver ALT and AST activities increased significantly (p<0.005) resulting to a decrease serum DRR (p<0.001) in test group.

Conclusion: PLP depletion may be partially responsible for the low serum DRR which is reputed to be a typical potent, non-invasive, economical and dynamic prognostic biomarker of alcoholic hepatitis.

Keywords:
Association, Pyridoxal-5'-phosphate, activities of aminotransferases, De Ritis ratio, alcohol hepatitis.

Article Details

How to Cite
Ndeh, F. J., Ojong, E. W., Akpan, U. O., Ekeagba, I. I., & Smella, M. N. (2021). Association between Pyridoxal-5’-Phosphate Levels, Liver Homogenates and Serum Activities of Aminotransferases and De Ritis Ratio amongst Alcoholic Hepatitis Patients. Asian Journal of Research and Reports in Hepatology, 3(1), 1-10. Retrieved from http://journalajrrhe.com/index.php/AJRRHE/article/view/30100
Section
Original Research Article

References

Athel Cornish-Bowden. Current IUBMB recommendations on enzyme nomenclature and kinetics, Perspectives in Science. 2014;1:74–87.
[PubMed] [Google Scholar]

Keith F. Tipton and Sinéad Boyce. History of the enzyme nomenclature system, Bio informatics. 2000;16(1):34-40.
[PubMed] [Google Scholar]

Hoffmann-Ostenhof O, Thompson RHS. International Commission on Enzymes, Nature. 1958;181:452.
[PubMed] [Google Scholar]

Nath P, Singh SP. Serum transaminases: Quo vadis. Biochem Anal Biochem. 2016;5:260.
DOI:10.4172/2161-1009.1000260
[PubMed] [Google Scholar]

Hoffmann‐Ostenhof O. Suggestions for a more rational classification and nomenclature of enzymes, November 2006, In book series: Advances in enzymology and related areas of molecular biology, Editor(s): F. F. Nord. 1953;14: 219-260.
[PubMed] [Google Scholar]

Masato Abei. Aspartate aminotransferase (AST), alanine aminotransferase (ALT). Nihon Rinsho. 2004;62(11):348-51.
PMID: 15628414 [PubMed] [Google Scholar]

Otto-Ślusarczyk D, Graboń W, Mielczarek-Puta M. Aspartate aminotransferase--key enzyme in the human systemic metabolism, Postepy Hig Med Dosw, Review. 2016;70:219-30.
DOI: 10.5604/17322693.1197373
PMID: 27117097. [PubMed] [Google Scholar]

Sakagishi Y, Alanine aminotransferase (ALT) Review, Nihon Rinsho. 1995;53(5):1146-50.
PMID: 7602770.
[PubMed] [Google Scholar]

De Rosa G, Swick RW. Metabolic implications of the distribution of the alanine aminotransferase isoenzymes. J Biol Chem. 1975;250(20):7961-7.
PMID: 1176455 [PubMed] [Google Scholar]

Vroon David H, Zafar Israili H, Kenneth Walker, W Dallas Hall, J Willis Hurst. In clinical methods: The history, physical, and laboratory examinations. 3rd edition. Butterworts Publishers. Amino transferases. 1990;99.
PMID: 21250265.
[PubMed] [Google Scholar]

Per Lindblom, Ingalill Rafter, Clive Copley, Ulf Andersson, Jesper Hedberg J, Anna-Lena Berg, Anders Samuelsson, Heike Hellmold, Ian Cotgreave, Björn Glinghammar. Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies. Arch Biochem Biophys. 2007;466(1):66-77.
DOI: 10.1016/j.abb.2007.07.023
Epub 2007 Aug 11PMID: 17826732. [PubMed] [Google Scholar]

Kallai L, Hahn A, Roeder V, Županic V. Correlation between histological findings and serum transaminase values in chronic diseases of the liver. Acta Medica Scandinavica. 1964;175:49-567.
[PubMed] [Google Scholar]

Boyd JW. Serum enzyme changes in lambs with experimentally-induced acute muscular dystrophy, Research in Veterinary Science. 1964;5(4):419-436.
[PubMed] [Google Scholar]

Vanderlinde RE. Review of pyridoxal phosphate and the transaminases in liver disease. Ann Clin Lab Sci. 1986;16(2):79-93.
PMID:3008634 [PubMed] [Google Scholar]

Esmond Snell E, Terry Jenkins W. The mechanism of the transamination reaction. Journal of Cellular and Comparative Physiology; 1959.
[PubMed] [Google Scholar]

Vázquez MA, Muñtoz F, Donoso J, García Blanco F. Transimination reaction between pyridoxal‐5′‐phosphate schiff bases with dodecylamine and amino acids. Journal of Physical Organic Chemistry., 2004;5(3):142-154.
DOI:10.1002/poc.610050306
[PubMed] [Google Scholar]

Robert Herbst M, Rittenberg D. The transamination reaction. the mechanism of the reaction between alpha keto acids and alpha amino acids. J. Org. Chem. 1943;08(4)380–389.
[PubMed] [Google Scholar]

Marino Martinez-Carrion, Tiemeier DC, Peterson Darrell L. Conformational properties of the isoenzymes of aspartate transaminase and the enzyme-substrate complexes, Biochemistry. 1970;9(13):2574–2582.
[PubMed] [Google Scholar]

Jee-Soo Lee, Kyunghoon Lee, Sung Min Kim, Moon Suk Choi, Sun Hee Jun, Woon Heung Song, Sang Hoon Song, Kyoung Un Park, Junghan Song. Effects of Pyridoxal-5′-Phosphate on aminotransferase activity assay, Lab Med Online. Korean. 2017;7(3):128-134.
[PubMed] [Google Scholar]

Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol and Alcoholism. 2004;39(4)336–339.
[PubMed] [Google Scholar]

Hafkenscheid JC, Dijt CC. Determination of serum aminotransferases: Activation by pyridoxal-5'-phosphate in relation to substrate concentration. Clin Chem. 1979;25(1):55-9.
[PubMed] [Google Scholar]

aKarmen A, Wroblewski F, Ladue JS. Transaminase activity in human Blood. J Clin Invest. 1955;34:126-131.
[PubMed] [Google Scholar]

International Federation of Clinical Chemistry (IFCC), Provisional Recommen-dation on (IFCC) Methods for the measurement of catalytic concentration of Enzyme, 1975. Clin. Chim. Acta 61, fig. –24 1976, Clin. Chim. Atcta, 70, fig. 42; 1974.
[PubMed] [Google Scholar]

Labadarios D, Rossouw JE, Mcconnell JB, Davis M, Androger Williams. Vitamin B6 deficiency in chronic liver disease- evidence for increased degradation of pyridoxal-5'-phosphate, Gut. 1977;18:23-27.
[PubMed] [Google Scholar]

Leevy CM, Baker H, Tenhove W, Frank O, Cherrick GR. B-complex vitamins in liver disease of the alcoholic. American Journal of Clinical Nutrition, 1965;16:339-346.
[PubMed] [Google Scholar]

Leevy CM, Thompson A, Baker H. Vitamins and liver injury. American Journal of Clinical Nutrition. 1970;23:493-498.

[PubMed] [Google Scholar]

Anna Mae Diehl, James Potter, John Boitnott, Mary Ann Van Duyn, Franklin Herlong H, Esteban Mezey. Relationship between Pyridoxal-5'-Phosphate deficiency and aminotransferase levels in alcoholic hepatitis, Gastroenterology. 1984;86:632-6.
[PubMed] [Google Scholar]

Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: The role of vitamin B6 deficiency. Clin Nephrol. 1995; 43(6):405-8.
[PubMed] [Google Scholar]

Ray Kim W, Steven Flamm L, Adrian Di Bisceglie M, Henry Bodenheimer C. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Annals of hepatology. 2008;47(4),1363-1370.
[PubMed] [Google Scholar]

Cohen JA, Kaplan MM. The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24:835-8.
[PubMed] [Google Scholar]

Shankhar Majhi, Nirmal Baral, Madhab Lamsal, Kishun Deo Mehta. De Ritis ratio as diagnostic marker of alcoholic liver disease, Nepal Med Coll J. 2006;8(1):40-2.
[PubMed] [Google Scholar]

Matloff DS, Selinger MJ, Ka plan MM. Hepatic transaminase activity in alcoholic liver disease. Gastroenterology. 1980;78:1389-92.
[PubMed] [Google Scholar]

Ning M, Baker H, Leevy CM. Reduction of glutamic pyruvic transaminase in pyridoxine deficiency in liver disease. Proc Soc Exp Bioi Med. 1966;121:27-30.
[PubMed] [Google Scholar]

Horder M, Moore RE, Bowers GN. Aspartate aminotransferase activity in human serum. Factors to be considered in suppl e-mentation with pyridoxal-5'-phosphate in vitro. Clin Chern. 1976;22:1876-83.
[PubMed] [Google Scholar]

Ludwig S, Kaplowitz N. Effect of pyridoxine deficiency on serum and liver transaminases in experimental liver injury in the rat. Gastroenterology. 1980;79:545-9.
[PubMed] [Google Scholar]

Caldwell EF, McHenry EW. Studies on vitamin B6 and transamination in rat liver. Arch Biochem Biophys. 1953;45:97-104.
[PubMed] [Google Scholar]

Brin M, Thiele VF. Relationsh ips between vitamin B6-vitamer content and the activities of two transaminase enzymes in rat tissues at varying intake levels of vitamin B6. J Nutr. 1967;93:213-21.
[PubMed] [Google Scholar]

Okada M, Kondo T. Effect of treatment with py ridoxine on aspartate aminotransferase activities in pyridoxine-deficie nt rat tissues. J Nutr Sci Vitaminol. 1982;28:69-75.
[PubMed] [Google Scholar]

Hans-Ulrich Bergmeyer Erich Bernt, Glutamate-Oxaloacetate Transaminase Methods of Enzymatic Analysis (Second Printing, Revised). Academic Press. 1965;837-845.
[PubMed] [Google Scholar]

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Bioi Chern. 1951;193:265-75.
[PubMed] [Google Scholar]

Lawrence Lumeng, Alec Lui, Ting-Kai Li. Microassay of Pyridoxal Phosphate Using PLP-dependent decarboxylation of L-[1- 14C] tyrosine by the apo-enzyme of tyrosine decarboxylase, Methods in Vitamin B-6 Nutrition, 1981;57-67.
[PubMed] [Google Scholar]

Chabner B, Livingston D. A simple enzymic assay for pyridoxal phosphate. Anal Biochem. 1970;34:413-23.
[PubMed] [Google Scholar]

Blackburn GL, Bistrain BR, Main i BS, Schlamm BA, Smith MF. Nutritional and rrietabolic assessment of the hospitalized patient. JPEN. 1977;1:11-22.
[PubMed] [Google Scholar].

Boitnott JK, Maddrey We. Alcoholic liver disease: I. Interrelationships among histologic features and the histologic effectsof prednisolone therapy. Hepatology. 1981;1:599-612.
[PubMed] [Google Scholar]

Li TK, Lumeng L, Veitch RL. Regulation of pyridoxal-5'-phosphate metabolism in liver. Biochem Biophys Res Commun. 1974;61:677-84. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press, 1967. [PubMed] [Google Scholar]

Majumdar SK, Shaw GK, Gorman PO, Aps EJ, Offerman EL, Thomson AD. Blood vitamin status (Bl , B2 , B6, folic acid and B12) in patients with alcoholic liver disease. Internat J Vit Nutr Res. 1982;52:266-71.
[PubMed] [Google Scholar]

Parker TH, Marshall JP, Roberts RK, et al., Effect of acute alcohol ingestion on plasma pyridoxal-5'-phosphate. Am J Clin Nutr. 1979;32:1246-52.
[PubMed] [Google Scholar]

Pierce HI, Mc Guffin RG, Hillman RS. Clinical studies in alcoholic sideroblastosis. Arch Int Med. 1976;136:283-9.
[PubMed] [Google Scholar]

Veitch RL, Lumeng L, Li TK. Vitamin B6 metabolism in chronic alcohol abuse. J Clin Invest. 1975;55:1026-3.
[PubMed] [Google Scholar]

Labadarios D, Rossouw JE, McConnell JB, Davis M, Williams R. Vitamin B6 deficiency in chronic liver disease-evidence for increased degradation of pyridoxal-5'-phosphate. Gut. 1977;18:23-7.
[PubMed] [Google Scholar]